Purchase Order 75F40121P00634
Award Date 9/24/21
Potential Completion Date 9/26/22
Potential Value $25K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Laurel, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company, provides a software license and device warranty for two GridION instruments to support the Food and Drug Administration's (FDA) next-generation sequencing efforts. The $25,000.00 firm-fixed-price purchase order has a period of performance through September 27, 2025. Oxford Nanopore Technologies is a provider of innovative nanopore-based sequencing platforms, which have been...
- This is a $125,000.00 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for a service agreement to provide Oxford Nanopore's GridION instruments located at the FDA's Center for Food Safety and Applied Nutrition, Office of Regulatory Science. This award is not set aside for any small business program. Oxford Nanopore has secured numerous federal contracts to...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a service contract to provide Oxford Nanopore GridION instruments. The contract has a total ceiling value of $50,000.00 and a completion date of February 5, 2023. The contract is not associated with any set-aside designation. Oxford Nanopore Technologies Inc. is a provider of next-generation genomic...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...
- This is a $12,550.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract is for the license and warranty of a GridION sequencing device, with an ultimate completion date of August 1, 2025. Oxford Nanopore Technologies has secured numerous federal contract awards to supply next-generation genomic sequencing equipment, consumables, and associated...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $25,000 purchase order to Oxford Nanopore Technologies Inc. for software licenses and device warranties in support of gridion instruments. This firm fixed price contract has a period of performance from September 2027 through September 2028 and will be performed in Calverton, Maryland. The award was set aside for total small business and will provide Oxford Nanopore Technologies Inc. with the ability...
- The Department of Health and Human Services Food and Drug Administration awarded a sole source, firm-fixed price purchase order to Oxford Nanopore Technologies Inc. in the amount of $100,060.00 for the acquisition of two GridION X5 devices. This award was made without a set-aside designation and has a completion date of January 21, 2020. The GridION X5 is a nanopore-based sequencing system used for genomic analysis applications such as infectious disease tracking and agricultural genomics....
- Oxford Nanopore Technologies Inc. was awarded a $100,060 firm fixed-price purchase order by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) for a total small business set-aside requirement of two portable long-read whole genome sequencers to support the FDA's epidemiologic investigations and surveillance for foodborne pathogens like Escherichia coli and Clostridium botulinum. The sequencers and associated consumables, support, and installation services are...
- This federal contract award is for the purchase of specific supplies and reagents for an Oxford Nanopore GridION instrument, awarded to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract, valued at $29,162.00, is a firm fixed-price purchase order placed by the Food and Drug Administration (FDA), a civilian government agency. The award is not associated with a set-aside program and has an ultimate completion date of March 29, 2024. Oxford Nanopore...
- The Food and Drug Administration awarded a $87,005 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned biotechnology company specializing in nanopore-based sequencing systems. The award, designated as a Total Small Business set-aside and issued on September 13, 2022, calls for the delivery of one long-read sequencing instrument and one automated library preparation instrument to the FDA's facility in New York, NY. The contract has an ultimate completion date...